Catalyst Pharmaceutical (CPRX) CPP-115

  • 0
  • 0

Welcome to CRWENewswire, Stocks to Watch. I am Shalika Jayasekera. Catalyst Pharmaceutical Partners Inc - CPRX - reported that a poster presentation about its next-generation GABA aminotransferase inhibitor, CPP-115, will be made on Dec. 3rd, 2011 at the American Epilepsy Society’s 65th Annual Meeting. The poster describes a study conclusions, demonstrating that CPP-115 suppresses infantile spasms (IS) in the rat multiple-hit model. IS is a rare seizure disorder of infancy and early childhood.

03 Dec 2011

60 Visualizações

cprx, crwenewswire

Estatísticas do vídeo



Vídeos em Destaque